Assertio, Lupin, Bausch Must Face Buyers' Price-Fixing Suit
A California federal judge has refused to dismantle a lawsuit alleging Bausch Health Co. and other pharmaceutical companies violated federal antitrust law by blocking a generic version of diabetes drug Glumetza...To view the full article, register now.
Already a subscriber? Click here to view full article